Plasma Fibronectin is Initially Decreased during Septicemia

References

• Mosesson MW. Cold-insoluble globulin (CIG), a circulating cell surface protein. Thromb Haemost 1977; 38: 742–750
   PubMed Web of Science ®Google Scholar
• Yamada K M, Olden K. Fibronectin-adhesive glycoprotein of cell surface and blood. Nature 1978; 275: 179–184
   PubMed Web of Science ®Google Scholar
• Pearlstein E, Gold L I, Gracia-Pardo A. Fibronectin: A review of its structure and biological activity. Mol Cell Biochem 1980; 29: 103–128
   PubMed Web of Science ®Google Scholar
• Rouslahti E, Engvall E, Hagman EG. Fibronectin: Current concepts of its structure and functions. Coll Res 1981; 1: 95–128
   Web of Science ®Google Scholar
• Hynes R O, Yamada KM. Fibronectins: Multifunctional modular glycoproteins. J Cell Biol 1982; 85: 369–377
   Google Scholar
• Mosher DF. Fibronectin. Prog Haemost Thromb 1980; 5: 111–151
   PubMedGoogle Scholar
• Blumenstock F A, Saba T M, Weber P, Laffin R. Biochemical and immunological characterization of human opsonic alpha-2-SB glycoprotein: Its identity with cold-insoluble globulin. J Biol Chem 1978; 253: 4287–4291
   PubMed Web of Science ®Google Scholar
• Blumenstock F A, Saba T M, Weber P, Cho E. Purification and biochemical characterization of a macrophage stimulating alpha-2-globulin opsonic protein. J Reticuloendothel Soc 1976; 19: 157–172
   PubMedGoogle Scholar
• Blumenstock F A, Weber P, Saba T M, Laffin R. Electroimmunoassay of alpha-2-opsonic protein levels during reticuloendothelial blockade. Am J Physiol 1977; 223: R80–R87
   Google Scholar
• Saba TM. Reticuloendothelial system host defenses after surgery and traumatic shock. Circ Shock 1975; 2: 91–108
   Google Scholar
• Saba T M, Jaffe E. Plasma fibronectin (opsonic glycoprotein): Its synthesis by vascular endothelial cells and role in cardio-pulmonary integrity after trauma as related to reticuloendothelial function. Am J Med 1980; 68: 577–594
   PubMed Web of Science ®Google Scholar
• Scovill W A, Saba T M, Kaplan J E, Bernard H R, Powers SR, Jr. Disturbances in circulating opsonic activity in man after operative and blunt trauma. J Surg Res 1977; 22: 709–716
   PubMed Web of Science ®Google Scholar
• Lanser M E, Saba T M, Scovill WA. Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Ann Surg 1980; 192: 776–782
   PubMed Web of Science ®Google Scholar
• Mosher D F, Williams EM. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med 1978; 91: 729–735
   PubMed Web of Science ®Google Scholar
• Rubli E, Bussard S, Frei E, Lundsgaard-Hansen P, Pappova E. Plasma fibronectin and associated variables in surgical intensive care patients. Ann Surg 1983; 197: 310–317
   PubMed Web of Science ®Google Scholar
• Scovill W A, Saba T M, Kaplan J E, Bernard H, Powers S. Deficits in reticuloendothelial humoral control mechanisms in patients after trauma. J Trauma 1976; 16: 898–904
   PubMed Web of Science ®Google Scholar
• Matsuda M, Yoshida N, Aoki N, Wakabayashi K. Distribution of cold-in soluble globulin in plasma and tissues. Ann NY Acad Sci 1978; 312: 74–92
   PubMedGoogle Scholar
• Couland J M, Labrousse J, Salmona J P, Tenaillon A, Lissac J, Jacqueol J, Beyne P, Rapin J, Allard D, Jeromett H. Plasma fibronectin concentrations in critically ill patients. Ric Clin Lab 1982; 12: 137–141
   PubMedGoogle Scholar
• Pott G, Lohmann J, Zundorf P, Gerlach U. Vermindertes Fibronectin in Plasma bei Patienten mil Sepsis und Schock. Dtsch Med Wochenschr 1981; 106: 532–534
   PubMedGoogle Scholar
• Boughton B J, Simpson A. Plasma fibronectin in acute leukaemia. Br J Haematol 1982; 51: 487–491
   PubMed Web of Science ®Google Scholar
• Choate J J, Mosher DF. Fibronectin concentration in plasma of patients with breast cancer, colon cancer and acute leukemia. Cancer 1983; 51: 1142–1147
   PubMed Web of Science ®Google Scholar
• Scovill W A, Annest S J, Saba T M, Blumenstock F A, Newell J C, Stratton H H, Powers SR. Cardiovascular hemodynamics after opsonic alpha-2-surface binding glycoprotein therapy in injured patients. Surgery 1979; 86: 284–293
   PubMed Web of Science ®Google Scholar
• Saba T M, Blumenstock F A, Scovill W A, Bernard HA. Cryoprecipitate reversal of opsonic alpha-2-surface binding giycoprotein deficiency in septic and trauma patients. Science 1978; 201: 622–624
   PubMed Web of Science ®Google Scholar
• Scovill W A, Saba T M, Blumenstock F A, Bernard H, Powers SR, Jr. Opsonic alpha-2-surface binding giycoprotein therapy during sepsis. Ann Surg 1978; 188: 521–529
   PubMed Web of Science ®Google Scholar
• Vuento M, Vaheri A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J 1979; 183: 331–337
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A, Randall J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Zardi L, Sin L, Carnemolla B, Cosutich E, Viale G, Santi L. A simplified procedure for preparation of antibodies to serum fibronectin. J Immunol Methods 1980; 34: 155–165
   PubMed Web of Science ®Google Scholar
• Marchalonies JJ. An enzymatic method for the trace iodination of immunoglobulins and other proteins. Biochem J 1969; 113: 299–305
   PubMed Web of Science ®Google Scholar
• Axén R, Porath J, Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature 1967; 214: 1302–1304
   PubMed Web of Science ®Google Scholar
• Stathakis N E, Founts A, Tsianos E. Plasma fibronectin in normal subjects and various disease states. J Clin Pathol 1981; 34: 504–508
   PubMed Web of Science ®Google Scholar
• Eriksen H O, Clemmensen I, Hansen M S, Ibsen KK. Plasma fibronectin concentration in normal subjects. Scand J Clin Lab Invest 1982; 42: 291–295
   PubMed Web of Science ®Google Scholar
• Kaplan J E, Saba TM. Humoral deficiency and reticuloendothelial depression after traumatic shock. Am J Physiol 1976; 230: 7–14
   PubMed Web of Science ®Google Scholar
• Simpson W A, Hasty D L, Mason J M, Beachey EH. Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun 1982; 37: 805–810
   PubMed Web of Science ®Google Scholar
• Van Der Water L, Destree A T, Hynes RO. Fibronectin binds to some bacteria but does not promote their uptake by phagocytic cell. Sience 1983; 220: 201–204
   PubMed Web of Science ®Google Scholar
• Doran J E, Raynor RH. Fibronectin binding to protein A-containing staphylococci. Infect Immun 1981; 33: 683–689
   PubMed Web of Science ®Google Scholar